JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 37 No. 6 978-982
© 1996 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chung, J.-K.
Right arrow Articles by Koh, C.-S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chung, J.-K.
Right arrow Articles by Koh, C.-S.

Bone Marrow Scintigraphy Using Technetium-99m-Antigranulocyte Antibody in Hematologic Disorders

June-Key Chung, Jeongseok Yeo, Dong-Soo Lee, Seonyang Park, Myung-Chul Lee, Byoung-Kook Kim and Chang-Soon Koh

Departments of Nuclear Medicine and Internal Medicine, Seoul National University Hospital, Seoul, Korea

Correspondence: For correspondence or reprints contact: June-Key Chung, MD, Department of Nuclear Medicine, Seoul National University Hospital, 28 Yungun-dong, Chongno-ku, Seoul 110-744, Korea.

ABSTRACT

Bone marrow is the primary site for many hematologic disorders. To date, however, no suitable bone marrow imaging method has been found. The present study investigates the usefulness of bone marrow immunoscintigraphy using 99mTc-labeled antigranulocyte antibody (anti-NCA-95) in 31 patients with hematologic disorders. Methods: One milligram of antibody labeled with 259–370 MBq 99mTc was injected intravenously, and bone marrow images were taken 4 hr later. We also calculated the uptake ratios of lumbar bone marrow-to-background (L/B) and ilium-to-background (I/B). Results: Of 15 patients with aplastic anemia, 7 showed diffusely decreased antibody uptake (L/B = 2.3 ± 0.8, I/B = 3.0 ± 0.8) compared to control patients (n = 21, L/B = 8.2 ± 2.5, I/B = 10.3 ± 3.1). Six patients had both decreased and increased uptake areas and two had normal to slightly increased uptake. Of those patients receiving various types of therapy for aplastic anemia, all but one showed increased or irregular uptake. The degree of antibody uptake in the bone marrow correlated with peripheral blood analyses (hemoglobin, white blood cells, platelets). Of six patients with myelodysplastic syndrome, four had irregular uptake and two diffusely decreased uptake. Four patients with myelogenous leukemia showed normal uptake, whereas two with lymphocytic leukemia had decreased uptake. Patients with iron deficiency anemia, pure red cell aplasia or thalassemia minor exhibited normal uptake with bone marrow expansion. Conclusion: Immunoscintigraphy with antigranulocyte antibody is a useful method for evaluating the bone marrow status of patients with various hematologic disorders.

Key Words: hematologic disorder • bone marrow scintigraphy • technetium-99m-anti-NCA-95 • aplastic anemia • myelodysplastic syndrome




This article has been cited by other articles:


Home page
JNMHome page
A. Agool, B. W. Schot, P. L. Jager, and E. Vellenga
18F-FLT PET in Hematologic Disorders: A Novel Technique to Analyze the Bone Marrow Compartment
J. Nucl. Med., October 1, 2006; 47(10): 1592 - 1598.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. Carr, S. F. Barrington, B. Madan, M. J. O'Doherty, C. A.B. Saunders, J. van der Walt, and A. R. Timothy
Detection of Lymphoma in Bone Marrow by Whole-Body Positron Emission Tomography
Blood, May 1, 1998; 91(9): 3340 - 3346.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1996 by the Society of Nuclear Medicine.